ea0063gp175 | Obesity (1) | ECE2019
Pellikaan Karlijn
, Elizabeth Melitza
, Donze Stephany
, van den Berg Sjoerd
, van Doorn Jaap
, Peeters Robin P
, Hokken-Koelega Anita CS
, de Graaff Laura CG
Introduction: Prader-Willi Syndrome (PWS) is a complex syndrome including hyperphagia, pituitary hormone deficiencies, low muscle mass and cognitive impairment. Treatment with recombinant Growth Hormone (GH) has beneficial effects on body composition, physical performance, cognition, psychomotor development, respiratory function, and quality of life of patients with PWS. GH treatment has a narrow therapeutic range. Clinicians measure serum immunoreactive Insulin-like Growth Fa...